Cargando…

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period

Recent progress in research on glucagon and α‐cells highlights their pathophysiological roles in diabetes. We previously showed that plasma glucagon levels measured by newly developed enzyme‐linked immunosorbent assay were dysregulated in patients with type 1 diabetes with respect to plasma glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamori, Dan, Katakami, Naoto, Takahara, Mitsuyoshi, Miyashita, Kazuyuki, Takebe, Satomi, Yasuda, Tetsuyuki, Matsuoka, Taka‐aki, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078088/
https://www.ncbi.nlm.nih.gov/pubmed/31465632
http://dx.doi.org/10.1111/jdi.13134
_version_ 1783507541895938048
author Kawamori, Dan
Katakami, Naoto
Takahara, Mitsuyoshi
Miyashita, Kazuyuki
Takebe, Satomi
Yasuda, Tetsuyuki
Matsuoka, Taka‐aki
Shimomura, Iichiro
author_facet Kawamori, Dan
Katakami, Naoto
Takahara, Mitsuyoshi
Miyashita, Kazuyuki
Takebe, Satomi
Yasuda, Tetsuyuki
Matsuoka, Taka‐aki
Shimomura, Iichiro
author_sort Kawamori, Dan
collection PubMed
description Recent progress in research on glucagon and α‐cells highlights their pathophysiological roles in diabetes. We previously showed that plasma glucagon levels measured by newly developed enzyme‐linked immunosorbent assay were dysregulated in patients with type 1 diabetes with respect to plasma glucose levels, suggesting dysregulated secretion. In the current study, the annual change in plasma glucagon levels was assessed in these same patients. We found that the plasma glucagon levels in the 66 Japanese patients involved in the study were significantly correlated between both years. In addition, they were significantly associated with serum blood urea nitrogen levels in a multivariate linear regression analysis, as reported in our previous study. The statistical correlation in glucagon levels between annual checkups and the sustained significant correlation between glucagon and blood urea nitrogen suggest a constant dysregulation of glucagon in association with altered amino acid metabolism in patients with type 1 diabetes.
format Online
Article
Text
id pubmed-7078088
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70780882020-03-19 Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period Kawamori, Dan Katakami, Naoto Takahara, Mitsuyoshi Miyashita, Kazuyuki Takebe, Satomi Yasuda, Tetsuyuki Matsuoka, Taka‐aki Shimomura, Iichiro J Diabetes Investig Articles Recent progress in research on glucagon and α‐cells highlights their pathophysiological roles in diabetes. We previously showed that plasma glucagon levels measured by newly developed enzyme‐linked immunosorbent assay were dysregulated in patients with type 1 diabetes with respect to plasma glucose levels, suggesting dysregulated secretion. In the current study, the annual change in plasma glucagon levels was assessed in these same patients. We found that the plasma glucagon levels in the 66 Japanese patients involved in the study were significantly correlated between both years. In addition, they were significantly associated with serum blood urea nitrogen levels in a multivariate linear regression analysis, as reported in our previous study. The statistical correlation in glucagon levels between annual checkups and the sustained significant correlation between glucagon and blood urea nitrogen suggest a constant dysregulation of glucagon in association with altered amino acid metabolism in patients with type 1 diabetes. John Wiley and Sons Inc. 2019-09-18 2020-03 /pmc/articles/PMC7078088/ /pubmed/31465632 http://dx.doi.org/10.1111/jdi.13134 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Articles
Kawamori, Dan
Katakami, Naoto
Takahara, Mitsuyoshi
Miyashita, Kazuyuki
Takebe, Satomi
Yasuda, Tetsuyuki
Matsuoka, Taka‐aki
Shimomura, Iichiro
Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
title Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
title_full Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
title_fullStr Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
title_full_unstemmed Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
title_short Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
title_sort consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078088/
https://www.ncbi.nlm.nih.gov/pubmed/31465632
http://dx.doi.org/10.1111/jdi.13134
work_keys_str_mv AT kawamoridan consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT katakaminaoto consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT takaharamitsuyoshi consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT miyashitakazuyuki consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT takebesatomi consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT yasudatetsuyuki consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT matsuokatakaaki consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod
AT shimomuraiichiro consistencyofplasmaglucagonlevelsinpatientswithtype1diabetesaftera1yearperiod